miR-31 controls osteoclast formation and bone resorption by targeting RhoA.
miR-31 controls osteoclast formation and bone resorption by targeting RhoA.
复制标题
DOI:
10.1186/ar4282
复制
发表时间:
2013
影响因子:
4.9
通讯作者:
Kohsaka H
中科院分区:
文献类型:
--
作者:
Mizoguchi F;Murakami Y;Saito T;Miyasaka N;Kohsaka H
Increased activity of osteoclasts is responsible for bone loss and joint destruction in rheumatoid arthritis. For osteoclast development and bone resorption activity, cytoskeletal organization must be properly regulated. MicroRNAs (miRNAs) are endogenous small noncoding RNAs that suppress expression of their target genes. This study was conducted to identify crucial miRNAs to control osteoclasts. miRNA expression in the bone marrow-derived macrophages (BMM) with or without receptor activator of nuclear factor κB ligand (RANKL) stimulation was analyzed by miRNA array. To examine the role of specific miRNAs in osteoclast formation, bone resorption activity and actin ring formation, the BMM were retrovirally transduced with miRNA antagomirs. To confirm whether the suppressive effects on osteoclastogenesis by miR-31 inhibition were mediated by targeting RhoA, osteoclast formation was analyzed in the presence of the RhoA inhibitor, exoenzyme C3. miR-31 was identified as one of the highly upregulated miRNAs during osteoclast development under RANKL stimulation. Inhibition of miR-31 by specific antagomirs suppressed the RANKL-induced formation of osteoclasts and bone resorption. Phalloidin staining of osteoclasts revealed that actin ring formation at the cell periphery was severely impaired by miR-31 inhibition, and clusters of small ringed podosomes were observed instead. In these osteoclasts, expression of RhoA, one of the miR-31 target genes, was upregulated by miR-31 inhibition in spite of the impaired osteoclastogenesis. Treatment with the RhoA inhibitor, exoenzyme C3, rescued the osteoclastogenesis impaired by miR-31 inhibition. miR-31 controls cytoskeleton organization in osteoclasts for optimal bone resorption activity by regulating the expression of RhoA.
登录
查看更多内容
影响因子:
3.3
作者:
Kurokawa, K;Matsuda, M
通讯作者:
Matsuda, M
影响因子:
4.8
作者:
Chellaiah, MA;Soga, N;Hruska, KA
通讯作者:
Hruska, KA
影响因子:
20.3
作者:
Sugatani, Toshifumi;Vacher, Jean;Hruska, Keith A.
通讯作者:
Hruska, Keith A.
影响因子:
4
作者:
Mizoguchi, Fumitaka;Izu, Yayoi;Noda, Masaki
通讯作者:
Noda, Masaki
影响因子:
64.5
作者:
Valastyan S;Reinhardt F;Benaich N;Calogrias D;Szász AM;Wang ZC;Brock JE;Richardson AL;Weinberg RA
通讯作者:
Weinberg RA